🇺🇸 FDA
Patent

US 10751409

Immunogenic compositions and uses thereof

granted A61KA61K2039/543A61K2039/55555

Quick answer

US patent 10751409 (Immunogenic compositions and uses thereof) held by The Board of Regents of the University of Texas System expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/543, A61K2039/55555, A61K39/12, A61K39/39